Sale of a medical technology company

The medical technology sector is one of the most innovative areas of the healthcare industry. AI, digital platforms and data-driven applications are transforming processes, products and business models. This opens up strategic options for growth, succession or sale for owners of medical technology companies. intelligentis supports you through this process in a structured and discreet manner, drawing on in-depth industry knowledge, from the preparatory stages right through to the handover of your life’s work.

Arrange a consultation

Industry expertise for technology-driven companies

Matthias Ehnert · Managing Director of intelligentis

Matthias Ehnert is a managing partner at intelligentis and a recognised expert in business sales within the medical technology sector. He has been advising on transactions in regulated and technology-intensive sectors for many years.

His in-depth understanding and specialist knowledge of medical technology business models, combined with a national and international network of strategic buyers and investors, form the basis for successful and sustainable succession solutions.

Market situation
Services
Achievements

Current market situation and specific features of the medical technology sector

The medical technology sector is one of the most innovative areas of the healthcare industry, but it faces structural challenges. Technological advances such as artificial intelligence and data-driven applications are driving new diagnostic and therapeutic solutions.

At the same time, a shortage of skilled workers and the stringent requirements of the EU Medical Devices Regulation are placing a particular strain on small and medium-sized enterprises. Delays in approvals and the growing demand for data-driven and AI-supported solutions are shaping the market.

Mergers and acquisitions are therefore a key tool for pooling technological capabilities, achieving economies of scale and ensuring competitiveness. Highly innovative medium-sized enterprises are a particular focus for strategic buyers, whilst market players such as the BVMed (Federal Association of Medical Technology ) promote professional exchange and represent the industry’s interests at political and regulatory levels.

Request a market assessment

Services relating to the sale of medical technology companies

intelligentis provides comprehensive support to medical technology entrepreneurs throughout the sales process. Our services range from structured sales preparation through to the successful handover to a suitable buyer.

The focus is on analysing the business model, the regulatory framework and the company’s technological positioning. intelligentis determines a realistic enterprise value and professionally prepares all sales documentation.

During the transaction, intelligentis manages the approach to potential buyers, coordinates due diligence processes and conducts negotiations. The post-transaction phase and handover period are also actively supported . Remuneration is purely performance-based.

Leverage sector expertise

Successful company sales in the medical technology sector

intelligentis continuously monitors the medical technology sector, regularly advises on company sales and supports manufacturers and service providers in this challenging environment. This valuable experience feeds directly into the strategic advice and positioning of companies.

A key component of this market knowledge is our own industry insights and publications, which provide guidance to business owners in a complex regulatory and technological environment.

By combining market monitoring, specialist expertise, a track record of successful transactions and personalised support, intelligentis creates a solid foundation for well-informed and sustainable sales decisions.

Arrange a reference meeting

Medical Technology Industry Newsletter, September 2019

intelligentis regularly reports on developments, trends and structural changes in the medical technology sector and presents these clearly in its own industry reports.

The Medical Technology Industry Newsletter for September 2019 provides a concise overview of market movements, regulatory frameworks and relevant transaction topics, highlighting intelligentis’ ongoing market monitoring and industry expertise.

The newsletter is available here: Medical Technology Industry Newsletter, September 2019.

Frequently asked questions about selling a business in the medical technology sector

The sale of a medical technology company involves specific technical and regulatory issues. Many business owners are seeking guidance on preparation, the process and valuation.

In a personalised and confidential consultation, we address these issues on a case-by-case basis and outline structured courses of action. Below you will find answers to key practical questions

Arrange a no-obligation initial consultation

How do I prepare my medical technology company for a sale?

Preparation for the sale begins with a structured analysis of the business model, organisation, product portfolio and regulatory status. This takes into account the company’s financial position and market standing

On this basis, intelligentis develops targeted measures to position the medical technology company in a value-oriented manner and lays the foundations for a clear, professionally managed sale process.

What is the process for selling a medical technology company?

The transaction process begins with strategic preparation and the drafting of the sales documentation. intelligentis identifies suitable buyers and targets them specifically.

Meanwhile, communication, due diligence and negotiations are coordinated, with a particular focus on the regulatory and technological requirements of the medical technology sector.

What does post-sale support involve following the sale of a medical technology company?

Following completion, intelligentis provides support during the post-transaction phase and assists the entrepreneur in stepping back from day-to-day operations. Handover processes are managed in a structured manner to ensure stability for staff, customers and partners.

Furthermore, intelligentis helps to safeguard contractual arrangements, with the aim of ensuring a smooth transition even after the closing.

How is the enterprise value of a medical technology company determined?

Business valuation in the medical technology sector is based on profitability, the level of innovation, the product and technology portfolio, and regulatory status under the MDR. Patents, quality management and scalability also play a role.

intelligentis takes into account current buyer expectations, comparable transactions and sector-specific risks in order to derive a realistic and marketable enterprise value.